MedTrace Logo

Adipose-derived Stem Cell Conditioned Media as a Novel Approach for Hair Regrowth in Male Androgenetic Alopecia

NCT05296863 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 37

Last updated 2022-03-25

No results posted yet for this study

Summary

This study investigated the efficacy of adipose derived stem cell conditioned media (ADSC-CM) combined with minoxidil for hair regeneration therapy in male AGA.

Conditions

  • Alopecia, Androgenetic
  • Hair Loss/Baldness

Interventions

COMBINATION_PRODUCT

Non-concentrated adipose-derived stem cell conditioned media and 5% Minoxidil

Non-concentrated ADSC-CM is given during week 0, 2, 4, and 6 on the left side of the scalp. Minoxidil is applied twice using a spray, in the morning and at night.

COMBINATION_PRODUCT

Concentrated adipose-derived stem cell conditioned media and 5% Minoxidil

Intervention is given during week 0, 2, 4, and 6 on the left side of the scalp. Minoxidil is applied twice using a spray, in the morning and at night.

COMBINATION_PRODUCT

Placebo and 5% Minoxidil

Intervention is given during week 0, 2, 4, and 6 on the right side of the scalp. Minoxidil is applied twice using a spray, in the morning and at night.

Sponsors & Collaborators

  • Kementerian Riset dan Teknologi / Badan Riset dan Inovasi Nasional, Indonesia

    collaborator OTHER_GOV

  • PT. Kimia Farma (Persero) Tbk

    collaborator INDUSTRY

  • Dr. dr. Lili Legiawati, SpKK(K)

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
58 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-10-11
Primary Completion
2021-12-03
Completion
2021-12-03

Countries

  • Indonesia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05296863 on ClinicalTrials.gov